TOTAL SYNTHESIS OF (+/-)-ALLIACOLIDE

DOI: 10.1016/S0040-4039(00)98750-1

Source and publish data:

Tetrahedron Letters p. 4413 - 4416 (1985)

Update date:2022-08-11

Topics:

Authors:

Ladlow, Mark

Pattenden, Gerald

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0040-4039(00)98750-1

A total synthesis of the unique epoxy-lactone alliacolide (3), featuring a novel, stereoselective intramolecular radical cyclisation onto an enolic double-bond, viz (13) ->(14), as a key step, is described.

Full text of DOI:10.1016/S0040-4039(00)98750-1

Products guided by the article

Product name:(+/-)-1-epi-alliacolide

Cas No:101834-24-6

R&D Labs maybe for 101834-24-6

Shanghai FWD Chemicals ltd

website:http://www.fwdchem.com

Contact:86-21-54450828

Address:Room 802,Lotus Tower ,159 Tianzhou Road,Xuhui District,Shanghai
Shandong Xiangde Biotechnology Co., Ltd

Contact:+86 -15066639877

Address:Sanba street
Sigma-Aldrich Chemie GmbH

website:http://www.sigmaaldrich.com

Contact:800 558-9160

Address:Industriestrasse 25CH-9471 Buchs SGSwitzerland
Jinan Yijialian Economic and Trade Development Co., Ltd.

Contact:+86 0531-66729596

Address:jinan
Hangzhou Neway Chemicals Co., Ltd.

Contact:+86-571-85095566

Address:Room 803, Qinglian Bldg, No 139 Qingchun Road, Hangzhou, Zhejiang China

Relevant to this article

Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl) amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: In vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's disease

Doi:10.1021/jm901618d
(2010)
Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway

Doi:10.1002/cmdc.201700063
(2017)
Doi:10.1039/f19726800814
()
Shedding light on the bimolecular interactions of Cafaminol and human serum albumin: spectroscopic characterization and in-silico investigation

Doi:10.1080/07391102.2020.1863262
(2020)
Fragmentation behavior of DOTA complexes under different activation conditions

Doi:10.1002/jms.3942
(2017)
Specific method for the fragmentation of the polypeptide chain of glycoproteins. Distribution of carbohydrate chains on the peptide core of blood-group-specific glycoprotein.

Doi:10.1016/0008-6215(83)88009-4
(1983)

Article Doi